Key Findings
- Crystalline glucosamine sulfate (1,500mg/day) reduced knee OA pain significantly (SMD = -0.47, 95% CI: -0.72 to -0.23, p < 0.001)
- Physical function (WOMAC) improved by a clinically meaningful amount (SMD = -0.34, p = 0.002)
- Joint space narrowing was reduced by 0.13mm over 3 years compared to placebo in long-term trials
- Glucosamine sulfate was significantly more effective than glucosamine hydrochloride across outcomes
- Onset of benefit typically occurred after 4-8 weeks of consistent supplementation